About Caraway Therapeutics
Caraway Therapeutics is a company based in Cambridge (United States) founded in 2018 was acquired by Merck in November 2023.. Caraway Therapeutics has raised $23 million across 1 funding round from investors including Merck, AbbVie and ARE. The company has 27 employees as of December 31, 2022.
- Headquarter Cambridge, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Caraway Therapeutics
Caraway Therapeutics has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series A round of $23 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $23.0M
-
First Round
First Round
(26 Nov 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Series A - Caraway Therapeutics | Valuation | MRLV , AbbVie |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Caraway Therapeutics
Caraway Therapeutics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, AbbVie and ARE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage therapeutics companies are invested in by MRLV.
|
Founded Year | Domain | Location | |
|
Venture capital investments are facilitated by Amgen-backed entity.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Caraway Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Caraway Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Caraway Therapeutics Comparisons
Competitors of Caraway Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Caraway Therapeutics
Frequently Asked Questions about Caraway Therapeutics
When was Caraway Therapeutics founded?
Caraway Therapeutics was founded in 2018.
Where is Caraway Therapeutics located?
Caraway Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Caraway Therapeutics a funded company?
Caraway Therapeutics is a funded company, having raised a total of $23M across 1 funding round to date. The company's 1st funding round was a Series A of $23M, raised on Nov 26, 2018.
How many employees does Caraway Therapeutics have?
As of Dec 31, 2022, the latest employee count at Caraway Therapeutics is 27.
What does Caraway Therapeutics do?
Caraway Therapeutics was founded in 2018 in Cambridge, United States, within the biotechnology sector focused on neurodegenerative diseases. Patient-derived induced pluripotent stem cells are utilized to generate neurons for drug testing. TRPML1 modulators are created to target lysosomes, aiming to restore their function and mitigate disease progression. Operations center on advancing these therapies through preclinical research.
Who are Caraway Therapeutics's investors?
Caraway Therapeutics has 8 investors. Key investors include Merck, AbbVie, ARE, MRLV, and Amgen Business Development.